Sign in

CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company

Tectonic Therapeutic, Inc.

Sign in to watch
Ticker
TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
810710585
Phone
(339) 666-3320
Business address
490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Former names
AvroBio, Inc., AVROBIO, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,920
in 2 filings, $14K under 10b5-1 plans

Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McNamara Peter −$14K Chief Scientific Officer sold 1% of stake

Reading 86 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-09 SPRINGER TIMOTHY A Director Grant or award · Stock Option (Right to Buy) +10,200 10,200
2025-04-11 SPRINGER TIMOTHY A Director Purchase +9,478 $16.31 $155K 4,334,846
2025-04-11 SPRINGER TIMOTHY A Director Purchase +53,706 $16.31 $876K 1,503,358
2025-04-10 SPRINGER TIMOTHY A Director Purchase +8,092 $16.73 $135K 4,325,368
2025-04-10 SPRINGER TIMOTHY A Director Purchase +45,858 $16.73 $767K 1,449,652
2025-04-09 SPRINGER TIMOTHY A Director Purchase +2,861 $14.62 $42K 4,316,419
2025-04-09 SPRINGER TIMOTHY A Director Purchase +857 $15.23 $13K 4,317,276
2025-04-09 SPRINGER TIMOTHY A Director Purchase +16,215 $14.62 $237K 1,398,938
2025-04-09 SPRINGER TIMOTHY A Director Purchase +4,856 $15.23 $74K 1,403,794
2025-04-07 SPRINGER TIMOTHY A Director Purchase +87,500 $17.10 $1.5M 4,313,558
2025-04-07 SPRINGER TIMOTHY A Director Purchase +412,500 $17.10 $7.1M 1,382,723
2025-04-07 MCGUIRE TERRANCE Director Sale −500,000 $17.10 $8.6M 573,062
2025-02-05 SPRINGER TIMOTHY A Director Purchase +129,294 $54.14 $7.0M 4,226,058
2025-02-05 SPRINGER TIMOTHY A Director Purchase +660,000 $50.00 $33.0M 970,223
2025-02-05 Lochner Daniel Chief Financial Officer Purchase +4,617 $54.14 $250K 4,617
2025-02-04 Schwabish Marc Chief Business Officer Grant or award +14,023 18,723
2025-02-04 Schwabish Marc Chief Business Officer Grant or award · Employee Stock Option (Right to Buy) +25,496 25,496
2025-02-04 McNamara Peter Chief Scientific Officer Grant or award +15,141 29,329
2025-02-04 McNamara Peter Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +27,530 27,530
2025-02-04 Lochner Daniel Chief Financial Officer Grant or award +18,074 18,074

Page 5 of 10 · 188 trades